Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incontinence Quiz (IQ): Translation, Cross-Cultural Adaptation, and Psychometric Validation of the French Version.

Healthcare (Basel, Switzerland)·2026
Same author

Molecular profiling and personalized medicine within EURACAN in the SPECTA Arcagen study in comparison to the France Genomic Medicine 2025 Plan in the AURAGEN platform in peritoneal mesotheliomas.

Translational oncology·2026
Same author

Pioneering insights into the diving behavior of early-stage sea turtles revealed by novel marine miniaturized satellite tags.

Scientific reports·2026
Same author

Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Genomic evolution and re-emergence of a multidrug-resistant <i>Clostridioides difficile</i> RT027 clone with reduced vancomycin susceptibility driving a prolonged hospital outbreak.

Emerging microbes & infections·2026
Same author

Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Cancer immunology research·2026

Related Experiment Video

Updated: May 30, 2026

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

Spontaneous pneumothorax: a 5-year experience.

Cristiana Sousa1, Joao Neves, Nuno Sa

  • 1Medicine Service, Unit D, Santo Antonio Hospital, Oporto Hospital Center, Porto, Portugal. cris_sevivas@yahoo.com.br

Journal of Clinical Medicine Research
|August 4, 2011
PubMed
Summary

This study on spontaneous pneumothorax (SP) found male predominance and a mean age of 34.5 years. While most cases presented acutely, a significant portion required surgical intervention, highlighting the need for improved clinical record-keeping.

More Related Videos

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Related Experiment Videos

Last Updated: May 30, 2026

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
05:50

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure

Published on: March 12, 2020

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Area of Science:

  • Pulmonology
  • Thoracic Surgery
  • Epidemiology

Background:

  • Spontaneous pneumothorax (SP) is defined as air in the pleural space without trauma.
  • It is classified as primary or secondary, with secondary SP linked to underlying lung disease.
  • Understanding SP epidemiology and treatment is crucial due to its incidence and management complexities.

Purpose of the Study:

  • To characterize the epidemiology of spontaneous pneumothorax.
  • To analyze clinical presentation, diagnostic investigations, and therapeutic choices for SP.
  • To evaluate recurrence rates and treatment outcomes in a 5-year casuistry.

Main Methods:

  • A retrospective analysis of 66 patients, encompassing 93 episodes of spontaneous pneumothorax.
  • Data collection focused on patient demographics, clinical symptoms, risk factors, and treatment strategies.
  • Statistical analysis was performed to identify associations and significant findings.

Main Results:

  • Male predominance was observed, with a mean age of 34.5 years.
  • Tobacco use was reported in 60.6% of cases; 36.4% were secondary SP.
  • Recurrence rates were 30.1% for secondary and 21.7% for primary SP; 29.1% of episodes required surgery.

Conclusions:

  • Findings align with existing literature on spontaneous pneumothorax.
  • Incomplete clinical records were noted, emphasizing the need for standardized data collection.
  • Improved documentation is essential for advancing knowledge and management of SP.